Lexpos News

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Phenobarbital 30mg and 60mg tablets. MSN/2026/010 Tier 2 – Medium impact Date of issue: 16 February 2026 Phenobarbital 30mg tablets and 60mg tablets (Teva) are out of stock until mid/late March 2026. Phenobarbital 60mg tablets (Accord) are out of stock until [...]

The post Medicine Supply Notification: Phenobarbital 30mg and 60mg tablets appeared first on Community Pharmacy England.

Major UK supermarket Morrisons is set to sell dozens of its community pharmacies in order to cut costs. Morrisons has launched a sale process after concluding that many of its in-store pharmacies are not financially viable. This news highlights the real economic peril facing pharmacy businesses and the urgent need for a sustainable funding model. [...]

The post Morrisons in-store pharmacy sales are yet another loud warning signal for Government and the NHS appeared first on Community Pharmacy England.

Community Pharmacy England has launched its fifth annual Pharmacy Pressures Survey, and we are keen to hear from all pharmacy owners and staff. The survey is crucial for monitoring the health of the sector. Its findings provide clear evidence of the realities facing community pharmacy. We know that being asked for feedback every year can [...]

The post Pharmacy Pressures Survey 2026: Your responses help secure our future appeared first on Community Pharmacy England.

Community Pharmacy England is aware of a recent increase in scam emails being sent to community pharmacies. Some of these messages falsely claim that the pharmacy is under investigation for a data protection or GDPR compliance breach. These emails can appear convincing at first glance. However, they often feature significant warning signs and should be [...]

The post Pharmacies urged to be alert to GDPR themed scam emails appeared first on Community Pharmacy England.

Following the completion of a safety review and the recommendations of the Commission on Human Medicines (CHM), the IXCHIQ Chikungunya vaccine is no longer indicated for adults over the age of 60 years, and is contraindicated in all individuals with hypertension, cardiovascular disease, diabetes mellitus, and/or chronic kidney disease. This action follows very rare fatal [...]

The post MHRA Drug Safety Update: IXCHIQ Chikungunya vaccine – updates to restrictions of use following safety review appeared first on Community Pharmacy England.